ABBV stock verdict - Avoid
ABBV
AbbVie Inc.
AVOIDHealthcare
$256.91
Fundamentals below bar
$256.91
Heavy$121.23Buy$161.63Fair$202.04Exit$242.45
FUNDAMENTAL47
TECHNICAL85
TRUST SCORE
30Very Low
confidence in this read — data completeness, earnings quality & coverage
Uptrend · EMA20 249.56 · EMA50 237.66 · EMA200 221.97 · RSI 66.1 · MACD below signal
PROS
- Revenue grew 12.4%/yr on average over the last 3 years
- High gross margin of 72% (3-yr avg)
- Price is in an uptrend — above key moving averages with positive momentum
CONS
- Trades above the model's exit level ($242.45) — overvalued on this framework
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
SECTOR PEERS
Analysis as of 2026-07-28 · price live, fundamentals from latest filings
FAQ
Why is ABBV rated Avoid?
ABBV (AbbVie Inc.) is rated Avoid because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Fundamentals below bar. Revenue grew 12.4%/yr on average over the last 3 years and High gross margin of 72% (3-yr avg)
Is ABBV overvalued right now?
ABBV is trading at $256.91 versus an estimated fair value of $202.04. That puts the stock in avoid territory on this framework. Trades above the model's exit level ($242.45) — overvalued on this framework
What should I watch before acting on ABBV?
Watch the trust score of 30, the earnings-quality checks, and any red flags. Trades above the model's exit level ($242.45) — overvalued on this framework